ASGCT and the Orphan Therapeutics Accelerator launched CGTxchange, an AI-enhanced clearinghouse and marketplace intended to reactivate cell and gene therapy programs that have been shelved despite supporting scientific and clinical evidence. The platform is designed to connect sponsors, investors, and development teams to restart valuable assets and reduce time lost to program abandonment.